ArticleFrontiers in pharmacology2018

HDAC6 Inhibition Promotes Transcription Factor EB Activation and Is Protective in Experimental Kidney Disease.

Angela S Brijmohan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.